Relative importance of the glycoprotein Ib-binding domain and the RGD sequence of yon Willebrand Factor for its interaction with endothelial cells

Blood

Volumn 90, Issue 6, 1997, Pages 2335-2344

  Perrault, Christelle ^b   Lankhof, Hanneke ^b   Pidard, Dominique ^b   Kerbiriou Nabias, Danièle ^b   Sixma, Jan J ^b   Meyer, Dominique ^b   Baruch, Dominique ^a  

^a BICÊTRE HOSPITAL   (France)

^b NONE

Author keywords

[No Author keywords available]

Indexed keywords

GLYCOPROTEIN IB;

ANIMAL CELL; ARTICLE; AUTOMATION; CELL ADHESION; CELL INTERACTION; ENDOTHELIUM CELL; FLOW CYTOMETRY; GENE DELETION; HAMSTER; HUMAN; HUMAN CELL; NONHUMAN; PRIORITY JOURNAL; QUANTITATIVE DIAGNOSIS; RECEPTOR UPREGULATION; VON WILLEBRAND DISEASE;

EID: 0030807310     PISSN: 00064971     EISSN: None     Source Type: Journal    
DOI: 10.1182/blood.v90.6.2335.2335_2335_2344     Document Type: Article

References (41)

1. Wagner DD: Cell biology of von Willebrand factor. Annu Rev Cell Biol 6:217, 1990
2. Meyer D, Girma JP: von Willebrand factor: Structure and function. Thromb Haemost 70:99, 1993
3. Lopez JA: The platelet glycoprotein Ib-IX complex. Blood Coagul Fibrinol 5:97, 1994
4. Sugimoto M, Ricca G, Hrinda ME, Schreiber AB, Searfoss GH, Bottini E, Ruggeri ZM: Functional modulation of the isolated glycoprotein Ib binding domain of von Willebrand factor expressed in Escherichia coli. Biochemistry 30:5202, 1991
5. Matsuhita T, Sadler JE: Identification of amino acid residues essential for von Willebrand factor binding to platelet glycoprotein Ib. J Biol Chem 270:13406, 1995
6. Savage B, Shattil SJ, Ruggeri ZM: Modulation of platelet function through adhesion receptors. A dual role for glycoprotein IIb-IIIa (integrin αIIbβ3) mediated by fibrinogen and glycoprotein Ib-von Willebrand factor. J Biol Chem 267:11300, 1992
7. Sugimoto M, Dent J, McClintock R, Ware J, Ruggeri ZM: Analysis of structure-function relationships in the platelet membrane glycoprotein Ib-binding domain of von Willebrand's factor by expression of deletion mutants. J Biol Chem 268:12185, 1993
8. Mohri H, Fujimura Y, Shima M, Yoshioka A, Houghten RA, Ruggeri ZM, Zimmerman TS: Structure of the von Willebrand factor domain interacting with glycoprotein Ib. J Biol Chem 263:17901, 1988
9. Berndt MC, Ward CM, Booth WJ, Castaldi PA, Mazurov AV, Andrews RK: Identification of aspartic acid 514 through glutamic acid 542 as a glycoprotein Ib-IX complex receptor recognition sequence in von Willebrand factor - Mechanism of modulation of von Willebrand factor by ristocetin and botrocetin. Biochemistry 31:11144, 1992
10. Plow EF, Pierschbacher MD, Ruoslahti E, Marguerie G, Ginsberg MH: The effect of Arg-Gly-Asp-containing peptides on fibrinogen and von Willebrand factor binding to platelets. Proc Natl Acad Sci USA 82:8057, 1985
11. Cheresh DA: Human endothelial cells synthesize and express an Arg-Gly-Asp-directed adhesion receptor involved in attachment to fibrinogen and von Willebrand factor. Proc Natl Acad Sci USA 84:6471, 1987
12. Dejana E, Lampugnani MG, Giorgi M, Gaboli M, Federici AB, Ruggeri ZM, Marchisio PC: von Willebrand factor promotes endothelial cell adhesion via an Arg-Gly-Asp mechanism. J Cell Biol 109:367, 1989
13. Sprandio JD, Shapiro SS, Thiagarajan P, McCord S: Cultured human umbilical vein endothelial cells contain a membrane glycoprotein immunologically related to platelet glycoprotein Ib. Blood 71:234, 1988
14. Asch AS, Adelman B, Fujimoto M, Nachman RL: Identification and isolation of a platelet GPIb-like protein in human umbilical vein endothelial cells and bovine aortic smooth muscle cells. J Clin Invest 81:1600, 1988
15. Konkle BA, Shapiro SS, Asch AS, Nachman RL: Cytokine-enhanced expression of glycoprotein Ibα in human endothelium. J Biol Chem 265:19833, 1990
16. Rajagopalan V, Essex DW, Shapiro SS, Konkle BA: Tumor necrosis factor a modulation of glycoprotein Ibα expression in human endothelial and erythroleukemia cells. Blood 80:153, 1992
17. Beacham DA, Wise RJ, Turd SM, Handin RI: Selective inactivation of the Arg-Gly-Asp-Ser (RGDS) binding site in von Willebrand factor by site-directed mutagenesis. J Biol Chem 267:3409, 1992
18. Beacham DA, Cruz MA, Handin RI: Glycoprotein Ib can mediate endothelial cell attachment to a von Willebrand Factor substratum. Thromb Haemost 73:309, 1995
19. Denis C, Williams JA, Lu X, Meyer D, Baruch D: Solid-phase von Willebrand factor contains a conformationally active RGD motif that mediates endothelial cell adhesion through the αvβ3 receptor. Blood 82:3622, 1993
20. Sixma JJ, Schiphorst ME, Verweij CL, Pannekoek H: Effect of deletion of the A1 domain of von Willebrand factor on its binding to heparin, collagen and platelets in the presence of ristocetin. Eur J Biochem 196:369, 1991
21. Lankhof H, Wu YP, Vink T, Schiphorst ME, Zerwes HG, de Groot PG, Sixma JJ: Role of the glycoprotein Ib-binding A1 repeat and the RGD sequence in platelet adhesion to human recombinant von Willebrand factor. Blood 86:1035, 1995
22. Lankhof H, van Hoeij M, Schiphorst ME, Bracke M, Wu YP, Ijsseldijk MJW, Vink T, de Groot PG, Sixma JJ: A3 domain is essential for interaction of von Willebrand factor with collagen type III. Thromb Haemost 75:950, 1996
23. Pietu G, Ribba AS, Cherel G, Siguret V, Obert B, Rouault C, Ginsburg D, Meyer D: Epitope mapping of inhibitory monoclonal antibodies to human von Willebrand factor by using recombinant cDNA libraries. Thromb Haemost 71:788, 1994
24. Nokes TJC, Mahmoud NA, Savidge GF, Goodall AH, Meyer D, Edgington TS, Hardisty RM: von Willebrand factor has more than one binding site for platelets. Thromb Res 34:361, 1984
25. Girma JP, Kalafatis M, Pietu G, Lavergne JM, Chopek MW, Edgington TS, Meyer D: Mapping of distinct von Willebrand factor domains interacting with platelet GPIb and GPIIb/ IIIa and with collagen using monoclonal antibodies. Blood 67:1356, 1987
26. Christophe O, Rouault C, Obert B, Pietu G, Meyer D, Girma JP: A monoclonal antibody (B724) to von Willebrand factor recognizing an epitope within the A1 disulfide loop (Cys 509-Cys 695) discriminates between type 2A and type 2B von Willebrand disease. Br J Haematol 90:195, 1995
27. Coller BS, Peerschke EI, Scudder LE, Sullivan CA: Studies with a murine monoclonal antibody that abolishes ristocetin-induced binding of von Willebrand Factor to platelets: Additional evidence in support of GPIb as a platelet receptor for von Willebrand factor. Blood 61:99, 1983
28. Meyer S, Kresbach G, Haring P, Schumpp-Vonach B, Clemetson KJ, Hadvàry P, Steiner B: Expression and characterization of functionally active fragments of the platelet glycoprotein (GP) Ib-IX complex in mammalian cells. J Biol Chem 268:20555, 1993
29. Miller JL, Hustad KO, Kupinski JM, Lyle VA, Kunicki TJ: Increased platelet sensitivity to ristocetin is predicted by the binding characteristics of a GPIb/IX determinant. Br J Haematol 74:313, 1990
30. Du X, Beutler L, Ruan C, Castaldi P, Berndt MC: Glycoprotein Ib and glycoprotein IX are fully complexed in the intact platelet membrane. Blood 69:1524, 1987
31. Pidard D, Renesto P. Berndt MC, Rabhi S, Clemetson KJ, Chignard M: Neutrophil proteinase cathepsin G is proteolytically active on the human platelet glycoprotein Ib-IX receptor: Characterization of the cleavage sites within the glycoprotein Ibα subunit. Biochem J 303:489, 1994
32. Newman PJ, Allen RW, Kahn RA, Kunicki TJ: Quantitation of membrane glycoprotein IIIa on intact human platelets using the monoclonal antibody AP3. Blood 65:227, 1985
33. Chuntharapai A, Bodary S, Horton MA, Jin Kim K: Blocking monoclonal antibodies to αvβ3 integrin: A unique epitope of αvβ3 integrin is present on human osteoclasts. Exp Cell Res 205:345, 1993
34. Kieffer N, Debili N, Wicki A, Titeux M, Henri A, Mishal Z, Breton-Gorius J, Vainchenker W, Clemetson KJ: Expression of platelet GPIbα in HEL cells. J Biol Chem 261:15854, 1986
35. Sambrook J, Fritsch EF, Maniatis T: Molecular Cloning: A Laboratory Manual (ed 2). Cold Spring Harbor, NY, Cold Spring Harbor Laboratory, 1989
36. Lopez JA, Chung DW, Fujikawa K, Hagen FS, Papayannopoulou T, Roth GJ: Cloning of the α chain of human platelet glycoprotein Ib: A transmembrane protein with homology to leucine-rich protein. Proc Natl Acad Sci USA 84:5615, 1987
37. Bahnak BR, Wu QY, Coulombel L, Assouline Z, Kerbiriou-Nabias D, Pietu G, Drouet L, Caen JP, Meyer D: Expression of von Willehrand factor in porcine vessels: Heterogeneity at the level of von Willebrand factor mRNA. J Cell Physiol 138:305, 1989
38. Defilippi P, Truffa G, Stefanuto G, Altruda F, Silengo L, Tarone G: Tumor necrosis factor α and interferon γ modulate the expression of the vitronectin receptor (integrin β3) in human endothelial cells. J Biol Chem 266:7638, 1991
39. Hashimoto Y, Ware J: Identification of essential GATA and Ets binding motifs within the promoter of the platelet glycoprotein Ibα gene. J Biol Chem 270:24532, 1995
40. Dichek D, Quertermous T: Variability in messenger RNA levels in human umbilical vein endothelial cells of different lineage and time in culture. In Vitro Cell Dev Biol 25:289, 1989
41. Page C, Rose M, Yacoub M, Pigot R: Antigenic heterogeneity of vascular endothelium. Am J Pathol 141:673, 1992